This report from Life Science Intelligence provides the latest market data for the Global Neuromodulation Devices Market. Information covered by this report includes:
This report covers the impact of COVID-19 on the neuromodulation devices market, including a recent forecast from 2020 to 2025. COVID-19 has also impacted leading competitors, such as Abbott, Boston Scientific, Medtronic, LivaNova, and others. The report provides insights into trends, drivers, and limiters of the neuromodulation devices market, as well as highlights potential opportunities.
Abbott
Advanced Bionics
B Braun
Cyberonics LivaNova
electroCore Medical
Medtronic
Nevro
Teleflex
Trusted By The Companies Pioneering What’s Next
Market Intelligence
Schedule an exploratory call
Request Info17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy